SUBSCRIBE
MENU
HOME
ABOUT US
Mission and Vision
Management
Board of Directors
Scientific Advisory Board
MYHEART™ PRODUCTS
Overview
Why MyHeart™?
Human Ventricular Cardiomyocytes
Cardiac Anisotropic Sheet
Cardiac Tissue Strip
Cardiac Organoid Chamber
SERVICES
Overview
Screening & Phenotyping Services
Consultation
RESOURCES
Downloads
Online References
Media Kit
INVESTORS
Overview
Stock Information
Press Releases
Financial Information
Corporate Governance
FAQs
Investor Contact
NEWS
Press Releases
Company Updates
Media Coverage
CONTACT
PRESS RELEASES
09
Sep
2019
Two new Pfizer-coauthored studies validate Novoheart’s pioneering human bioengineered heart tissues and chambers for improving drug development
04
Sep
2019
Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2019 Financial Results
28
Jun
2019
Novoheart Holdings Inc. Completes Acquisition of Xellera Therapeutics
17
Jun
2019
Novoheart Announces Appointment of New Chief Financial Officer
28
May
2019
Novoheart to Acquire Xellera Therapeutics
<
1
2
3
4
5
>
Last ›
Subscribe To Our Newsletter
Fill out the following to subscribe and start receiving updates from us!
Subscribe Now
No Thanks
